Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Intercept Pharmaceuticals

Intercept Pharmaceuticals reported $-31543000 in EBITDA for its fiscal quarter ending in March of 2023.

Ebitda Change
Acadia Pharmaceuticals ACAD:US USD -53158000 7.58M
Alnylam Pharmaceuticals ALNY:US USD -135742000 38.56M
Amgen AMGN:US USD 3B 42M
Arrowhead Research ARWR:US USD 50.84M 90.27M
AstraZeneca AZN:LN USD 4.28B 965M
Biogen BIIB:US USD 686.7M 312.1M
Bluebird Bio BLUE:US USD -83411000 8.1M
Bristol-Myers Squibb BMY:US USD 5.43B 772M
Eli Lilly LLY:US USD 1.96B 528.3M
Esperion Therapeutics ESPR:US USD -48524000 6.1M
Gilead Sciences GILD:US USD 2.24B 456M
GlaxoSmithKline GSK:LN GBP 2.56B 960M
Incyte Corp INCY:US USD 48.82M 62.76M
Intercept Pharmaceuticals ICPT:US USD -31543000 13.66M
Ionis Pharmaceuticals IONS:US USD -110937000 93.44M
Moderna Inc MRNA:US USD -288000000 1.95B
Neurocrine Biosciences NBIX:US USD 34.7M 73.1M
Novartis NOVN:VX USD 4.72B 217M
PTC Therapeutics PTCT:US USD -74790000 53.3M
Regeneron Pharmaceuticals REGN:US USD 1.1B 195.4M
Sangamo BioSciences SGMO:US USD 80.09M 132.14M
Sarepta Therapeutics SRPT:US USD -126783000 30.5M
Vertex Pharmaceuticals VRTX:US USD 817.8M 254.1M